NDAINHALATIONAEROSOL, METERED
Approved
Jan 2023
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
2
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Pharmacologic Class:
Corticosteroid
Indications (1)
Clinical Trials (2)
GRANITE: Airsupra Effectiveness in the Real World
Started Jul 2025
4,000 enrolled
Asthma
Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma
Started Sep 2024
101 enrolled
Mild Asthma
Loss of Exclusivity
LOE Date
May 28, 2030
51 months away
Patent Expiry
May 28, 2030
Exclusivity Expiry
Sep 15, 2028
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 9415009 | May 28, 2030 | U-3509 |